To ask the Secretary of State for Health and Social Care, whether he plans to carry out Vorasidenib trials on patients that have undergone (a) radiotherapy and (b) chemotherapy.
Research is crucial in tackling brain cancer, which is why the Department spends £1.5 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR), with cancer as one of the largest areas of i...
Vorasidenib